J

Japan Tissue Engineering Co Ltd
TSE:7774

Watchlist Manager
Japan Tissue Engineering Co Ltd
TSE:7774
Watchlist
Price: 536 JPY -2.9% Market Closed
Market Cap: 21.8B JPY

Net Margin
Japan Tissue Engineering Co Ltd

-17.5%
Current
-15%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-17.5%
=
Net Income
-401.3m
/
Revenue
2.3B

Net Margin Across Competitors

No Stocks Found

Japan Tissue Engineering Co Ltd
Glance View

Market Cap
21.8B JPY
Industry
Biotechnology

Japan Tissue Engineering Co., Ltd. engages in the research, development, and manufacture of cultured biological cells and tissues. The company is headquartered in Gamagori-Shi, Aichi-Ken and currently employs 200 full-time employees. The company went IPO on 2007-12-21. The firm operates its business in two segments. The TEP segment is engaged in the research and development of self-cultured epidermis, self-cultured cartilages and self-cultured corneal epithelium for medical institutions. The Research and Development Supports segment is engaged in the development, manufacture and sale of laboratory human cultured tissues based on tissue engineering technology and manufacturing know-how for cosmetic and pharmaceutical product manufacturers.

Intrinsic Value
305.07 JPY
Overvaluation 43%
Intrinsic Value
Price
J
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-17.5%
=
Net Income
-401.3m
/
Revenue
2.3B
What is the Net Margin of Japan Tissue Engineering Co Ltd?

Based on Japan Tissue Engineering Co Ltd's most recent financial statements, the company has Net Margin of -17.5%.

Back to Top